Abiopharma

🔍 COZADD BRUCE C (Director)

Company: Jazz Pharmaceuticals plc (JAZZ)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Sold 3,684 shares of Ordinary Shares at $190.222 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 386,998.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,292 shares of Ordinary Shares at $190.9383 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 384,706.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 24 shares of Ordinary Shares at $191.7447 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 384,682.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.
• F2: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.60 to $190.5603. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
• F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $190.6051 to $190.5982. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.